New growth hormone secretagogues:: C-terminal modified sulfonamide-analogues of NN703

被引:5
|
作者
Peschke, B
Hansen, BS
机构
[1] Novo Nordisk AS, Hlth Care Chem, DK-2760 Malov, Denmark
[2] Novo Nordisk AS, Diabet Biochem, DK-2880 Bagsvaerd, Denmark
关键词
D O I
10.1016/S0960-894X(99)00167-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The C-terminal the orally active growth hormone secretagogue NN703 was changed to prepare analogues with inverse sulfonamides and inverse amides. The compounds showed high activity in a in vitro rat pituitary model. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1295 / 1298
页数:4
相关论文
共 50 条
  • [1] Growth hormone secretagogues derived from NN703 with hydrazides as c-terminal
    Ankersen, M
    Nielsen, KK
    Hansen, TK
    Raun, K
    Hansen, BS
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (05) : 487 - 497
  • [2] C-terminal ether analogues of NN703
    Madsen, K
    Andersen, P
    Ankersen, M
    Peschke, B
    Sehested, B
    Soerensen, J
    BIOPOLYMERS, 2005, 80 (04) : 553 - 553
  • [3] C-terminal ether analogs of NN703
    Madsen, Kjeld
    Andersen, Peter
    Ankersen, Michael
    Peschke, Bernd
    Sehested, Birgit
    Soerensen, Jan
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 383 - +
  • [4] Highly potent growth hormone secretagogues: Hybrids of NN703 and ipamorelin
    Hansen, TK
    Ankersen, M
    Raun, K
    Hansen, BS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1915 - 1918
  • [5] Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency
    Svensson, J
    Monson, JP
    Vetter, T
    Hansen, TK
    Savine, R
    Kann, P
    Bex, M
    Reincke, M
    Hagen, C
    Beckers, A
    Ilondo, MM
    Zdravkovic, M
    Bengtsson, BÅ
    Korbonits, M
    CLINICAL ENDOCRINOLOGY, 2003, 58 (05) : 572 - 580
  • [6] Synthesis of piperazinones and their application in constrained mimetics of the growth hormone secretagogue NN703
    Hansen, TK
    Schlienger, N
    Hansen, BS
    Andersen, PH
    Bryce, MR
    TETRAHEDRON LETTERS, 1999, 40 (18) : 3651 - 3654
  • [7] Pharmacokinetic and pharmacodynamic modeling of NN703, a growth hormone secretagogue, after a single po dose to human volunteers
    Agerso, H
    Ynddal, L
    Sogaard, B
    Zdravkovic, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (02): : 163 - 169
  • [8] The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers
    Zdravkovic, M
    Sogaard, B
    Ynddal, L
    Christiansen, T
    Agerso, H
    Thomsen, MS
    Falch, JE
    Ilondo, MM
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 (04) : 193 - 198
  • [9] C-TERMINAL SEQUENCE OF PIG GROWTH HORMONE
    MILLS, JB
    NATURE, 1967, 213 (5076) : 631 - &
  • [10] A C-TERMINAL SEQUENCE FROM OX GROWTH HORMONE
    WALLIS, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1966, 115 (02) : 423 - &